Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
72.69
-1.22 (-1.65%)
At close: Jan 30, 2026, 4:00 PM EST
72.70
+0.01 (0.01%)
After-hours: Jan 30, 2026, 5:41 PM EST
Kymera Therapeutics Analyst Ratings
Total Analysts
24
Consensus Rating
Strong Buy
Price Target
$105.96
Upside
+45.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $119 → $133 | Buy | Maintains | $119 → $133 | +82.97% | Jan 28, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $138 | Strong Buy | Reiterates | $138 | +89.85% | Jan 15, 2026 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 6, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $80 → $117 | Strong Buy | Maintains | $80 → $117 | +60.96% | Dec 22, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $70 → $103 | Buy | Maintains | $70 → $103 | +41.70% | Dec 16, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $65 → $110 | Buy | Maintains | $65 → $110 | +51.33% | Dec 11, 2025 |
| Mizuho | Mizuho | Buy Maintains $81 → $120 | Buy | Maintains | $81 → $120 | +65.08% | Dec 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $70 → $125 | Buy | Maintains | $70 → $125 | +71.96% | Dec 10, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $73 → $122 | Strong Buy | Maintains | $73 → $122 | +67.84% | Dec 9, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $80 → $110 | Strong Buy | Maintains | $80 → $110 | +51.33% | Dec 9, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $69 → $116 | Buy | Maintains | $69 → $116 | +59.58% | Dec 9, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $80 → $116 | Strong Buy | Maintains | $80 → $116 | +59.58% | Dec 9, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $67 → $120 | Buy | Maintains | $67 → $120 | +65.08% | Dec 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $73 → $127 | Buy | Maintains | $73 → $127 | +74.71% | Dec 9, 2025 |
| Barclays | Barclays | Buy Maintains $70 → $119 | Buy | Maintains | $70 → $119 | +63.71% | Dec 9, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $98 → $125 | Buy | Reiterates | $98 → $125 | +71.96% | Dec 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.